Article thumbnail

Renal Autotransplantation and Extracorporeal Nephron-Sparing Surgery for De Novo Renal Cell Carcinoma in a Kidney Allograft

By PhD MD Shinichiro Ono, PhD MD Takashi Kenmochi, PhD MD Taihei Ito, MD Naohiro Aida, PhD MD Kazunori Otsuki, PhD MD Naotake Akutsu, PhD MD Michihiro Maruyama, PhD MD Mamoru Kusaka, PhD MD Ryoichi Shiroki and PhD MD Kiyotaka Hoshinaga


Abstract. De novo renal cell carcinoma (RCC) rarely occurs in kidney allografts; however, the risk of RCC in these patients is 100-fold that of the general healthy population. Although total nephrectomy has been the standard treatment for kidney allograft RCC, several authors have reported that early-stage RCC in kidney allografts was successfully treated with nephron-sparing surgery. We herein describe a new procedure involving renal autotransplantation and extracorporeal nephron-sparing surgery, which was performed to treat de novo RCC near the hilum of a transplanted kidney. In the 22 months since transplantation, the patient's renal function has been favorable, and no recurrence has been observed. In conclusion, renal autotransplantation is a feasible technique for the treatment of RCC in kidney allografts, especially RCC located near the hilum

Topics: Surgery, RD1-811
Publisher: Wolters Kluwer
Year: 2017
DOI identifier: 10.1097/TXD.0000000000000714
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.